PlainPharmaWatch

CMS Open Payments · Program Year 2024

OWP Pharmaceuticals, Inc.

OWP Pharmaceuticals, Inc. reported $7,780.60 in payments to 412 physicians and teaching hospitals across 412 transactions.

$7.8K
Total payments
412
Transactions
412
Recipients
−$696.59
General Payments vs PY2023

OWP Pharmaceuticals, Inc. reported $7,780.60 in payments to 412 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1662 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $18.88 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

The verdict

OWP Pharmaceuticals, Inc. pairs modest payment volume with an unusually diversified payment pattern across a wide recipient base.

#1662
of 1,925 companies
0.0%
of all US industry payments
0.0%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

OWP Pharmaceuticals, Inc.'s CMS-reported General Payments decreased by $696.59 (−8.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: OWP PHARMACEUTICALS, INC.PY2023: OWP PHARMACEUTICALS, INC.PY2024: OWP Pharmaceuticals, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$8.5KPY2024$7.8K
PY2023
$8,477.19
PY2024
$7,780.60

How OWP Pharmaceuticals, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

OWP Pharmaceuticals, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$7,781 14th percentile higher than 14% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). This entry sits in this band. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for OWP Pharmaceuticals, Inc.

Rank #1662 of 1,925 companies in CMS Open Payments for 2024 belongs to OWP Pharmaceuticals, Inc., which reported $7,780.60 across 412 transactions to 412 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $18.88 per transaction and $18.88 per recipient.

The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $7.8K, accounting for 100.0% of the company's reported total and 412 transactions.

General Payment Breakdown by Type

OWP Pharmaceuticals, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $7.8K, 100.0% of the company's reported total.

How OWP Pharmaceuticals, Inc. divides its payments

How the reported total splits across payment categories

1. Food and Beverage$7.8K
Payment Type Amount Transactions
Food and Beverage $7.8K 412

Recipient Concentration in General Payments

The five largest recipient relationships account for $384.31 (4.9%) of $7,780.60 in this company's General Payments records across 354 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for OWP Pharmaceuticals, Inc.

The five named recipients with the highest reported General Payments from this company

Lameck Symekah NP$84.49Eunice Ontita APRN$84.49Assumpta U Nwagwu Np$72.87Diana C Manjarres MD$72.87Tamara O'nan$69.59
  1. 1

    Lameck Symekah NP

    $84.49 across 4 reported transactions

  2. 2

    Eunice Ontita APRN

    $84.49 across 4 reported transactions

  3. 3

    Assumpta U Nwagwu Np

    $72.87 across 3 reported transactions

  4. 4

    Diana C Manjarres MD

    $72.87 across 3 reported transactions

  5. 5

    Tamara O'nan

    $69.59 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $18.88. Average per recipient: $18.88.

Total Amount

$7,780.60

Avg per Transaction

$18.88

Avg per Recipient

$18.88

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

OWP Pharmaceuticals, Inc. Share

0.0%

#1662 by total payments

Frequently Asked Questions

How much did OWP Pharmaceuticals, Inc. pay to physicians and hospitals in 2024?
OWP Pharmaceuticals, Inc. made $7,780.60 in payments to physicians and hospitals in Program Year 2024, across 412 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from OWP Pharmaceuticals, Inc.?
412 physicians and teaching hospitals received payments from OWP Pharmaceuticals, Inc. in 2024, averaging $18.88 per recipient.
What types of payments did OWP Pharmaceuticals, Inc. make?
OWP Pharmaceuticals, Inc. made 1 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Food and Beverage" at $7.8K, representing 100.0% of the company's reported total.
How does OWP Pharmaceuticals, Inc. rank among pharmaceutical companies?
By total payment amount, OWP Pharmaceuticals, Inc. sits at #1662 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from OWP Pharmaceuticals, Inc.?
The average transaction from OWP Pharmaceuticals, Inc. was $18.88 in 2024. The company made 412 total transactions to 412 recipients.
Where does the payment data for OWP Pharmaceuticals, Inc. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download OWP Pharmaceuticals, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.